Company / FCF Margin
Arcutis Biotherapeutics, Inc. FCF Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-1.7%
FY2025
5-year range
-57.1% / -1.7%
FY2024-FY2025
Trend
+97.1%
vs FY2024
Sector context
#62 of 133
Health Care
What the data says
At -1.7%, Arcutis Biotherapeutics, Inc.'s fcf margin ranks #62 of 133 in the Health Care sector.
Based on SEC 10-K filings.
-1.7% in FY2025.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#62 of 133 in Health CareTop 47% of 133This company -1.7% Sector average -632.8%
▼
+99.7% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 97.1% year-over-year.
- Currently 631.2pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1.7% | +97.1% |
| FY2024 | -57.1% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026